In addition, selective inhibition of STAT3 by small molecule inhibitors suppresses CD44+/CD24−/ALDH+ BCSCs, mammosphere-forming efficiency and tumor growth in human breast tumor xenograft rodents [260]. Here, STAT3 is linked to neoplasm.